Altered regulation of nitric oxide and natriuretic peptide system in cisplatin-induced nephropathy

Regulatory Peptides

Volumn 174, Issue 1-3, 2012, Pages 65-70

  Kim, Chang Seong ^a   Choi, Joon Seok ^a   Park, Jeong Woo ^a   Bae, Eun Hui ^a   Ma, Seong Kwon ^a   Lee, JongUn ^a   Kim, Soo Wan ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Cisplatin; Guanylyl cyclase; Natriuretic peptide; Nitric oxide

Indexed keywords

3 NITROTYROSINE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CISPLATIN; CREATININE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE TYPE C; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; SODIUM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CISPLATIN INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME ACTIVITY; ENZYME LOCALIZATION; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PAPILLA; MALE; MOLECULAR PATHOLOGY; NEPHROTOXICITY; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; SINGLE DRUG DOSE; SODIUM EXCRETION; TISSUE DISTRIBUTION;

ANIMALS; CISPLATIN; GUANYLATE CYCLASE; KIDNEY DISEASES; MALE; NATRIURETIC PEPTIDES; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS;

EID: 84862815269     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.12.001     Document Type: Article

References (31)

1. Arany I., Safirstein R.L. Cisplatin nephrotoxicity. Semin Nephrol 2003, 23:460-464.
2. Hutchison F.N., Perez E.A., Gandara D.R., Lawrence H.J., Kaysen G.A. Renal salt wasting in patients treated with cisplatin. Ann Intern Med 1988, 108:21-25.
3. Kim S.W., Lee J.U., Nah M.Y., Kang D.G., Ahn K.Y., Lee H.S., Choi K.C. Cisplatin decreases the abundance of aquaporin water channels in rat kidney. J Am Soc Nephrol 2001, 12:875-882.
4. Zou A.P., Cowley A.W. Role of nitric oxide in the control of renal function and salt sensitivity. Curr Hypertens Rep 1999, 1:178-186.
5. Ito S. Nitric oxide in the kidney. Curr Opin Nephrol Hypertens 1995, 4:23-30.
6. Goligorsky M.S., Brodsky S.V., Noiri E. Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002, 61:855-861.
7. Plato C.F., Shesely E.G., Garvin J.L. eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux. Hypertension 2000, 35:319-323.
8. Kone B.C. Nitric oxide in renal health and disease. Am J Kidney Dis 1997, 30:311-333.
9. Forstermann U., Mulsch A., Bohme E., Busse R. Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res 1986, 58:531-538.
10. Greenwald J.E., Needleman P., Wilkins M.R., Schreiner G.F. Renal synthesis of atriopeptin-like protein in physiology and pathophysiology. Am J Physiol 1991, 260:F602-F607.
11. Potthast R., Potter L.R. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptors. Peptides 2005, 26:1001-1008.
12. Suga S., Nakao K., Hosoda K., Mukoyama M., Ogawa Y., Shirakami G., Arai H., Saito Y., Kambayashi Y., Inouye K., et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992, 130:229-239.
13. Winquist R.J., Faison E.P., Waldman S.A., Schwartz K., Murad F., Rapoport R.M. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle. Proc Natl Acad Sci U S A 1984, 81:7661-7664.
14. Braughler J.M. Soluble guanylate cyclase activation by nitric oxide and its reversal. Involvement of sulfhydryl group oxidation and reduction. Biochem Pharmacol 1983, 32:811-818.
15. Severina I.S. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide. Biochemistry (Mosc) 1998, 63:794-801.
16. Kim S.W., Lee J., Park J.W., Hong J.H., Kook H., Choi C., Choi K.C. Increased expression of atrial natriuretic peptide in the kidney of rats with bilateral ureteral obstruction. Kidney Int 2001, 59:1274-1282.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
18. Torres V.E., Hui Y.S., Shah S.V., Northrup T.E., Dousa T.P. Cyclic nucleotide phosphodiesterases in glomeruli of rat renal cortex. Kidney Int 1978, 14:444-451.
19. Julou-Schaeffer G., Gray G.A., Fleming I., Schott C., Parratt J.R., Stoclet J.C. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990, 259:H1038-H1043.
20. Franke E.D., Lucas C.M. San Roman E. Antibody response of humans to the circumsporozoite protein of Plasmodium vivax. Infect Immun 1991, 59:2836-2838.
21. Eiserich J.P., Patel R.P., O'Donnell V.B. Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules. Mol Aspects Med 1998, 19:221-357.
22. Chirino Y.I., Trujillo J., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., Bobadilla N.A., Pedraza-Chaverri J. Selective iNOS inhibition reduces renal damage induced by cisplatin. Toxicol Lett 2008, 176:48-57.
23. Meurer S., Pioch S., Pabst T., Opitz N., Schmidt P.M., Beckhaus T., Wagner K., Matt S., Gegenbauer K., Geschka S., Karas M., Stasch J.P., Schmidt H.H., Muller-Esterl W. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation. Circ Res 2009, 105:33-41.
24. Ormond P.M., Basinger M.A., Jones M.M., Hande K.R. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats. J Pharmacol Exp Ther 1992, 262:246-251.
25. Nagano N., Yagi M., Kato S., Furuya Y., Miyata S., Manabe N. Renal responses to atrial natriuretic peptide (ANP) in rats with non-oliguric acute renal failure induced by cisplatin. J Vet Med Sci 1995, 57:997-1002.
26. Goetz K.L., Wang B.C., Geer P.G., Leadley R.J., Reinhardt H.W. Atrial stretch increases sodium excretion independently of release of atrial peptides. Am J Physiol 1986, 250:R946-R950.
27. Singer D.R., Shore A.C., Markandu N.D., Buckley M.G., Sagnella G.A., MacGregor G.A. Dissociation between plasma atrial natriuretic peptide levels and urinary sodium excretion after intravenous saline infusion in normal man. Clin Sci (Lond) 1987, 73:285-289.
28. Hirata Y., Hirose S., Takata S., Takagi Y., Matsubara H. Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells. Eur J Pharmacol 1987, 135:439-442.
29. Elesgaray R., Caniffi C., Ierace D.R., Jaime M.F., Fellet A., Arranz C., Costa M.A. Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide. Regul Pept 2008, 151:130-134.
30. Costa M.A., Elesgaray R., Balaszczuk A.M., Arranz C. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regul Pept 2006, 135:63-68.
31. Caniffi C., Elesgaray R., Gironacci M., Arranz C., Costa M.A. C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats. Peptides 2010, 31:1309-1318.